Konya Training and Research Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT02576340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Konya Beyhekim Training and Research Hospital | Konya Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (4)

ampicillin (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

otilonium bromide (1 trial)

sulbactam (unasyn) (1 trial)

Drugs in Other Trials (1)

tramadol (Ultram) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acalculous Cholecystitis (Phase 4)

Cholecystitis (Phase 4)

Cholecystitis, Acute (Phase 4)

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Gallstones (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5